Loading data
ABMNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 8.75 bn USD | 8.36 bn USD | 8.1 bn USD | 7.81 bn USD |
| Cost of revenue | 7.67 bn USD | 7.33 bn USD | 7.04 bn USD | 6.76 bn USD |
| Selling, general and administrative expense | 697.4 m USD | 765.3 m USD | 572.8 m USD | 628.3 m USD |
| Operating profit | 311.7 m USD | 212 m USD | 409.5 m USD | 348.8 m USD |
| Interest expense | — | — | 82.3 m USD | 41.1 m USD |
| Profit before tax | 219.9 m USD | 133.6 m USD | 331.1 m USD | 310 m USD |
| Income tax expense | 57.6 m USD | 52.2 m USD | 79.7 m USD | 79.6 m USD |
| Net income (reported basis) | 162.4 m USD | 81.4 m USD | 251.3 m USD | 230.4 m USD |
| Basic earnings per share | 2.61 USD/share | 1.29 USD/share | 3.81 USD/share | 3.44 USD/share |
| Diluted earnings per share | 2.59 USD/share | 1.28 USD/share | 3.79 USD/share | 3.41 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.